Deepali Pal
Has grant
Senior Lecturer
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Deepali Pal is a Senior Lecturer at Northumbria University in the United Kingdom. Her research areas include leukemia treatment, specifically focusing on patient-derived leukemia cells, organoid engineering, and the bone marrow microenvironment. Recent publications highlight her work on therapy targeting and treatment resistance in acute leukemias, as well as innovative methods to replace animal procedures in drug testing.
Recent Grants
Grant: Close
3D bioprinted microtissues to develop patient-specific non-animal technologies (NAT) in cancer drug development
Open Date: 2021-01-04
Close Date: 2024-01-03
Grant: Close
An industrial standard cancer drug development platform using human induced pluripotent stem cell technology
Open Date: 2017-01-01
Close Date: 2018-12-31
Grant: Close
An industrial standard cancer drug development platform using human induced pluripotent stem cell technology
Open Date: 2017-01-01
Close Date: 2018-12-31
Articles (10)
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2020
Collaborators (13)
Lisa Russell
Senior Lecturer in Childhood Cancer and Haematology
Newcastle University
Andrew Filby
Deputy Dean
Newcastle University
Oscar Molina
-
Pablo Rodriguez-Gonzalez
Associate Professor
University of Oviedo
Sophie Kellaway
Assistant Professor
University of Nottingham
Simon Bomken
Newcastle University
Jan‐Henning Klusmann
-
Peter Keane
Assistant Professor
University of Birmingham
Alan J Warren
University of Cambridge
James Allan
Professor of Cancer Genetics
Newcastle University
Stephen Todryk
Professor of Immunology
Northumbria University
Venetia Bigley
MRC Senior Clinical Fellow, Clinical Senior Lecturer in Haematology
Newcastle University
Claus Meyer
Head of DCAL, PhD
Goethe University Frankfurt
Make your next move.
Prepare your application
Review drafts before you send them.